Quince Therapeutics Inc (QNCX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -83,979 | -44,521 | -31,079 | -15,030 | -56,828 |
| Depreciation Amortization | -872 | -723 | -523 | -323 | 14,968 |
| Income taxes - deferred | -4,963 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -940 | 214 | -1,417 | 22 | 927 |
| Other Working Capital | 12,843 | 373 | 179 | 2,051 | -484 |
| Other Operating Activity | 36,486 | 13,713 | 11,824 | 3,679 | 9,513 |
| Operating Cash Flow | $-41,425 | $-30,944 | $-21,016 | $-9,601 | $-31,904 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 57,997 | N/A | 31,000 | N/A | 111,727 |
| PPE Investments | -352 | -348 | -274 | -148 | -257 |
| Purchase Of Investment | -34,418 | -29,496 | -13,789 | -1,954 | -89,562 |
| Sale Of Investment | N/A | 45,000 | N/A | 13,000 | N/A |
| Investing Cash Flow | $23,227 | $15,156 | $16,937 | $10,898 | $21,908 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 17,909 | 15,875 | 14,499 | 87 | 225 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -5,000 |
| Financing Cash Flow | $17,909 | $15,875 | $14,499 | $87 | $-4,775 |
| Exchange Rate Effect | -114 | 153 | 194 | 175 | 231 |
| Beginning Cash Position | 6,212 | 6,212 | 6,212 | 6,212 | 20,752 |
| End Cash Position | 5,809 | 6,452 | 16,826 | 7,771 | 6,212 |
| Net Cash Flow | $-403 | $240 | $10,614 | $1,559 | $-14,540 |
| Free Cash Flow | |||||
| Operating Cash Flow | -41,425 | -30,944 | -21,016 | -9,601 | -31,904 |
| Capital Expenditure | -352 | -348 | -274 | -148 | -257 |
| Free Cash Flow | -41,777 | -31,292 | -21,290 | -9,749 | -32,161 |